Overactive Bladder News, Treatment Studies | OAB Research Articles

Overactive Bladder (OAB)


Patients with refractory OAB most likely represent a minority of the total OAB population.

AUA Updates Overactive Bladder Guideline

Updated OAB guideline now says clinicians may consider combination therapy with an antimuscarinic and beta3-andrenoceptor agonist for patients refractory to monotherapy with either of those medications.
Training can help reduce salt and fluid intake.

Some Nocturia Cases May Be Eased By Restricting Salt Intake

Decreasing salt intake may benefit patients with nocturia who are heavy salt users, according to a new study published in Neurourology and Urodynamics. In a prospective study, Tomohiro Matsuo, MD, and colleagues from Nagasaki University Graduate School of Biomedical Sciences in Nagasaki, Japan, analyzed changes in lower urinary tract symptoms in 321 patients with nocturia…

Overactive Bladder Treatment: Which Is the Most Cost-Effective Option?

Study authors developed a Markov model with health states based on daily urinary incontinence episodes (UIEs) to compare the cost-effectiveness of onabotulinumtoxinA, implantable sacral nerve stimulation devices, percutaneous tibial nerve stimulation, anticholinergic medications, and mirabegron versus BSC for the management of refractory OAB.
Next post in Overactive Bladder (OAB)